Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:50765rdf:typepubmed:Citationlld:pubmed
pubmed-article:50765lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:50765lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:50765lifeskim:mentionsumls-concept:C0205246lld:lifeskim
pubmed-article:50765lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:50765lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:50765pubmed:issue1lld:pubmed
pubmed-article:50765pubmed:dateCreated1975-11-8lld:pubmed
pubmed-article:50765pubmed:abstractTextSilybine is the main active substance of the polyhydroxyphenylchromanone derivatives extracted from the seeds of Silybum Marianum. In the normal albinos rat, this pure compound (from 2 mg/100 g) lowers directly the systemic blood pressure. It does not increase vascular permeability. It potentiates post-serotonine hypertension. Silybine antagonizes cutaneous oedemas and suppresses the fall of blood pressure induced by dextran polymers. It inhibits anaphylactic shock in rats sensitized by ovalbumine. Silybine seems to be a stabilizer of mastcells membranes, thus preventing histamine release.lld:pubmed
pubmed-article:50765pubmed:languagefrelld:pubmed
pubmed-article:50765pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:50765pubmed:citationSubsetIMlld:pubmed
pubmed-article:50765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:50765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:50765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:50765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:50765pubmed:statusMEDLINElld:pubmed
pubmed-article:50765pubmed:monthMarlld:pubmed
pubmed-article:50765pubmed:issn0301-4533lld:pubmed
pubmed-article:50765pubmed:authorpubmed-author:LecomteJJlld:pubmed
pubmed-article:50765pubmed:issnTypePrintlld:pubmed
pubmed-article:50765pubmed:volume214lld:pubmed
pubmed-article:50765pubmed:ownerNLMlld:pubmed
pubmed-article:50765pubmed:authorsCompleteYlld:pubmed
pubmed-article:50765pubmed:pagination165-76lld:pubmed
pubmed-article:50765pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-An...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-An...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Ra...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Bl...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-De...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Hi...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Fl...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Ca...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Hi...lld:pubmed
pubmed-article:50765pubmed:meshHeadingpubmed-meshheading:50765-Si...lld:pubmed
pubmed-article:50765pubmed:year1975lld:pubmed
pubmed-article:50765pubmed:articleTitle[General pharmacologic properties of silybine and silymarine in the rat].lld:pubmed
pubmed-article:50765pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:50765pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:50765pubmed:publicationTypeEnglish Abstractlld:pubmed